We hypothesize that in APP/PS1 mice, as seen in human early AD cases [11], Glo-1 activity is reduced despite normal expression of the enzyme because of the reduced levels of cofactor GSH required for Glo-1 function. The gene discussed is APP; the disease is Alzheimer disease.